← Today’s ReceiptsSource pending
Public-record receiptR-TXSource pending
Ted Cruz disclosed SELL $GS
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$100K – $250K
Filed
2025-11-12
Trade date
2025-11-11
Disclosure lag
1 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 1 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $100K – $250K, which is the public reporting band rather than an exact profit or loss figure.
419 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Ted Cruz, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 12 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-11-12 · disclosed 1d after transaction
Market context
Goldman Sachs Group Inc.
Sector: Financials
Post-trade move: 40.1%
Vs SPY: 29.8%
Factual flags
- 12 lobbying filings linked to this ticker.
- 19 nearby same-ticker disclosures in the surrounding 30-day window.
- GS transaction date was 22d after a public lobbying filing by GOLDMAN SACHS GROUP INC ($640,000); this is timing context, not a finding of intent.
- 4 members disclosed GS within a 7-day span starting 2025-11-10.
- Disclosed range upper bound: $250,000.
Member trail
Ted Cruz
U.S. Senate · TX
Senate Committee on CommerceScienceand TransportationSenate Committee on Foreign RelationsSenate Committee on Rules and AdministrationSenate Committee on the Judiciary
Ticker trail
$GS
Goldman Sachs Group Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.